Prime position to capitalise on the €43.3bn European medical cannabis opportunity
Regulatory change is underway in multiple EU countries to allow medical prescriptions utilising THC.
Partnership with the highly regarded neighbouring American Farm School in Greece which is focused on genetics R&D.
We are building a proprietary IP protected library of genetics for pain indicator treatment.
The management team have medical cannabis cultivation experience at scale, coupled with significant experience at both Greek governmental and wider EU levels
Our vertically integrated model spans cultivation, production, distribution and sales, and a proprietary genetic research databank – all supported by best in class global partners.